Whole tumor section quantitative image analysis maximizes between-pathologists' reproducibility for clinical immunohistochemistry-based biomarkers
Authors:
Open Access
- 1 December 2017
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 97 (12) , 1508-1515
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Interobserver Concordance in Implementing the 2010 ASCO/CAP Recommendations for Reporting ER in Breast CarcinomasAmerican Journal of Clinical Pathology, 2013
- External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scaleJournal of Experimental & Clinical Cancer Research, 2013
- Digital Imaging in Pathology: Whole-Slide Imaging and BeyondAnnual Review of Pathology: Mechanisms of Disease, 2013
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working GroupJNCI: Journal of the National Cancer Institute, 2011
- Implementation of a Canadian External Quality Assurance Program for Breast Cancer BiomarkersApplied Immunohistochemistry & Molecular Morphology, 2009
- Facilitating consensus by examining patterns of treatment effectsThe Breast, 2009
- Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancerBreast Cancer Research, 2008
- Estrogen- and Progesterone-Receptor Status in ECOG 2197: Comparison of Immunohistochemistry by Local and Central Laboratories and Quantitative Reverse Transcription Polymerase Chain Reaction by Central LaboratoryJournal of Clinical Oncology, 2008
- Prognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors in a Randomized Trial Comparing Letrozole and Tamoxifen Adjuvant Therapy for Postmenopausal Early Breast Cancer: BIG 1-98Journal of Clinical Oncology, 2007
- Molecular Markers for Predicting Response to Tamoxifen in Breast Cancer PatientsEndocrine, 2000